Menu Search

Denmark

OMX Copenhagen 20Last 5 days
Last price1,773.08
S&P GSCILast 5 days
Last price562.92

Loading...

DKK overview

PairLatest rateToday's change1 year change
DKKGBP0.1161
GBP		0.0001 / 0.08%--
DKKEUR0.1338
EUR		-0.00002 / -0.01%--
DKKUSD0.155
USD		-0.0002 / -0.13%--
DKKJPY24.47
JPY		-0.073 / -0.30%--
DKKAUD0.232
AUD		-0.0003 / -0.13%--
DKKCAD0.2157
CAD		-0.0003 / -0.14%--
DKKCNY1.08
CNY		-0.0014 / -0.13%--
DKKCHF0.1241
CHF		-0.0005 / -0.39%--

Equity fund country flows

This chart shows the cumulative weekly equity in country flows into or out of Denmark in USD. EPFR Global provides global coverage of foreign investor flows, tracking over 15,000 funds domiciled around the world.
As of May 19 2021.

Market movers

Constituents of the OMX Copenhagen 20 with the highest percent gain over one day.
ListingLastChangeVolume
Novo Nordisk A/SNOVO B:CPH388.90
DKK		+23.70
+6.49%		13.94m
Oersted A/SORSTED:CPH135.50
DKK		+4.45
+3.40%		2.64m
Zealand Pharma A/SZEAL:CPH419.50
DKK		+12.20
+3.00%		266.03k
Genmab A/SGMAB:CPH2,185.00
DKK		+21.00
+0.97%		104.30k
Demant A/SDEMANT:CPH233.00
DKK		+1.80
+0.78%		413.09k
FLSmidth & Co A/SFLS:CPH519.00
DKK		+4.00
+0.78%		195.69k
Pandora A/SPNDORA:CPH550.00
DKK		+4.20
+0.77%		485.50k
Nkt A/SNKT:CPH796.50
DKK		+3.00
+0.38%		123.18k
Coloplast A/SCOLO B:CPH577.40
DKK		+0.600
+0.10%		208.94k
Data delayed at least 15 minutes, as of Jan 16 2026 15:59 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.